Alcon
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.
| Company type | Public (Aktiengesellschaft) |
|---|---|
Traded as | |
| Industry | Ophthalmology |
| Founded | 1945 in Fort Worth, Texas, United States |
| Headquarters | , United States |
Key people | David Endicott (CEO) |
| Products |
|
| Revenue | US$9.46 billion (2023) |
| US$1.04 billion (2023) | |
Net income | US$974 million (2023) |
| Total assets | US$29.6 billion (2023) |
| Total equity | US$20.6 billion (2023) |
Number of employees | 25,315 (FTE, 2023) |
| Website | alcon |
| Footnotes / references | |
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.